Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Bioverativ
Biotech
GBT adds 2 Sanofi sickle cell meds in deal worth up to $353M
In exchange for the global rights to the assets, Sanofi will receive up to $353 million in an upfront fee and milestone payments.
Amirah Al Idrus
Mar 16, 2021 9:55am
Sanofi nabs speedy review of sutimlimab
May 15, 2020 8:15am
Ex-Bioverativ CEO John Cox lands at Torque Therapeutics
Oct 2, 2019 7:43am